QualityStocksNewsBreaks Archives - Page 953 of 1388

ThursdayJan 23, 2020 10:04 am

QualityStocksNewsBreaks – OriginClear Inc. (OCLN) Enters Strategic Partnership with India’s Permionics for Asia-Pacific Region

OriginClear (OTCQB: OCLN), a leading provider of water treatment solutions, today announced its entry into a strategic partnership with Permionics Separations Solutions, Inc., a unit of India’s Permionics Group (Permionics) for the Asia-Pacific Region. Permionics, based in the Indian state of Gujarat, is a leading Indian liquid separations company, specializing in water treatment. Per the update, as OriginClear’s strategic partner, Permionics intends to greatly expand their mutual presence throughout Asia and the Pacific. “OriginClear has recognized that market penetration into another region of the world is best accomplished in conjunction with a solid player in that region,” Satyajai Major, Managing…

ThursdayJan 23, 2020 9:28 am

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX.V: VIVO) (OTCQX: VVCIF) to Commence Trading on the Toronto Stock Exchange; Provides Cannabis 2.0 Update

VIVO Cannabis (TSX.V: VIVO) (OTCQX: VVCIF), an Ontario-based cannabis company recognized for its premium products and services, today announced that its common shares are set to start trading on the Toronto Stock Exchange (“TSX”) under the symbol ‘VIVO’ at market open on January 24, 2020. The company’s common shares will be voluntarily delisted from the TSX Venture Exchange in connection with the TSX listing. “The strength of the Toronto Stock Exchange is world-class, and this event represents a tremendous milestone for VIVO,” VIVO Cannabis CEO Barry Fishman stated in the news release. “We believe the TSX listing will increase VIVO's…

WednesdayJan 22, 2020 1:40 pm

QualityStocksNewsBreaks – Jerrick Media Holdings Inc. (JMDA) Launches New Challenges Feature on Vocal

Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, today announced the launch of Challenges on its proprietary long-form digital publishing platform Vocal. Through friendly competition, Challenges are intended to inspire new brands and creators to join the Vocal community. Multiple Challenges across a range of topics will be offered each month for creators to participate in for the chance to win cash prizes, experiences, and more. “Challenges are the most important product update introduced into Vocal to date, allowing creators to connect with brands in an authentic,…

WednesdayJan 22, 2020 10:06 am

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Places Hold on Reverse Split, Plans Entry into Regulated and Licensed Portion of Cannabis Marketplace

Sugarmade (OTCQB: SGMD) today announced that it has placed a hold on plans to complete a reverse split of its common shares. Per the update, pending a vote by its board of directors, management believes temporarily holding or canceling the reverse split may be the best future course of action. In addition, Sugarmade announced its planned entry into the regulated and licensed portion of the cannabis marketplace, with an emphasis on the California distribution and retail sectors. “For at least the time being, we do not see a reason to move forward with the reverse stock split. However, we reserve…

WednesdayJan 22, 2020 10:00 am

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) to Provide Patented DehydraTECH(TM) to Cannadips’ Cannabis Products in California and Across the US

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced that it has reached a new definitive agreement to provide its patented DehydraTECH(TM) technology to Cannadips' cannabis products, both in its current California market and across the United States. According to the update, Lexaria's DehydraTECH fast-acting, high-absorption technology is perfectly suited to improve consumer satisfaction and the dipping experience. Terpene-rich multi spectrum oils are base ingredients of Cannadips THC, and DehydraTECH is able to reduce throat irritation normally associated with some terpenes. Inferior products utilize less efficacious cannabis isolate without terpenes that lack the entourage…

WednesdayJan 22, 2020 9:30 am

QualityStocksNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) Closes Fully Subscribed Private Placement

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) on Tuesday announced the closing of a non-brokered, fully subscribed private placement of 7,692,307 units at a price of $0.065 each for total proceeds of $500,000. Each unit consists of one common share and one half of one common share purchase warrant of the company. Each warrant authorizes the holder to receive, for no additional consideration, one common share, subject to adjustments, at an exercise price of $0.15 for 24 months from the date of issuance. All securities issued are subject to a 4-month and one day hold period in Canada. PowerBand…

WednesdayJan 22, 2020 9:21 am

QualityStocksNewsBreaks – Grapefruit Boulevard Investments, Inc. (IGNG) Files Amendment No. 1 to Registration Statement

Grapefruit Boulevard Investments (“GBI”), a licensed and fully compliant California based cannabis distribution and manufacturing company and a wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG) (collectively “Grapefruit”), this morning announced that it has filed Amendment No. 1 to its Registration Statement on Form S-1 that was originally filed on July 28, 2019 regarding conversions of convertible notes issued to the company’s institutional investor Auctus Fund, LLC. “We are very pleased to file the Amendment which puts us back on track to complete the Auctus transaction. Pursuant to the terms of our Agreements with Auctus, immediately upon effectiveness of the…

TuesdayJan 21, 2020 2:10 pm

QualityStocksNewsBreaks – Jerrick Media Holdings Inc. (JMDA) CEO Discusses Future Uplisting in Weekly Update

Jerrick Media Holdings (OTCQB: JMDA), a holding company that gives technology products the resources and opportunities to make ideas a reality, recently published a weekly update from the company’s CEO Jeremy Frommer discussing relevant news, updates and insights. Among other highlights in this week’s update, Frommer discussed the company’s strategies for the year, including a planned uplisting from the OTCQB to the NASDAQ Capital Market. “As we approach the uplisting period, based on all the workflows my team is managing, including S-1 paperwork, NASDAQ application documents, financing and revenue generation, I can see the uplisting window narrowing to the last…

TuesdayJan 21, 2020 10:37 am

QualityStocksNewsBreaks – Youngevity International Inc.’s (NASDAQ: YGYI) Khrysos Industries, Inc. Secures $1.2M of Tolling Revenue for February

Youngevity International (NASDAQ: YGYI), a leading multi-channel lifestyle company operating in three distinct business segments including a commercial coffee enterprise and a commercial hemp enterprise, together with its wholly owned subsidiary, Khrysos Industries, Inc., today announced that its tolling operation within its 82,000 square foot facility in Orlando, Florida has filled 42% of its available capacity generating $1.2 million of revenue for February tolling production. According to the update, Khrysos Industries tolling operation represents one revenue segment of Youngevity's hemp enterprise. “Our current capacity for our tolling operations, at current prices, provides us the opportunity to generated monthly revenue of…

TuesdayJan 21, 2020 10:27 am

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Receipt of U.S. FDA Fast Track Designation for Immunogene Therapy that Targets Lung Cancer

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, nonviral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that the U.S Food and Drug Administration (FDA) has granted Fast Track Designation for Genprex’s Oncoprex(TM) immunogene therapy in combination with EGFR inhibitor osimertinib (AstraZeneca’s Tagrisso(R)). Tagrisso(R), with worldwide sales of $1.86 billion in 2018 and $2.31 billion in the first 9 months of 2019, is currently AstraZeneca’s highest grossing product for the treatment of non-small cell lung cancer (NSCLC) patients with EFGR mutations that progressed after treatment with osimertinib alone. Genprex has treated more…

Site Search

Company Search

Category: QualityStocksNewsBreaks